Xilis, Inc.
Biotechnology company · Durham, North Carolina, United States
Xilis, Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2019. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $3.8 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $19 million sold in a notice filed in 2025.
Xilis at a glance
What does Xilis do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $3.8 million in total (2022 to 2024). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $19.4 million sold (2025).
Frequently asked questions about Xilis
Where is Xilis headquartered?
Xilis, Inc. is headquartered in Durham, North Carolina, United States.
What does Xilis do?
Xilis, Inc. is a biotechnology company.
When was Xilis founded?
The earliest incorporation on record for Xilis, Inc. is in 2019, according to public company registers.
Similar companies
- Humacyte, Inc.Durham, North Carolina, United States
- Precision Biosciences IncDurham, North Carolina, United States
- Deep Blue Medical Advances, Inc.Durham, North Carolina, United States
- inSoma Bio, Inc.Durham, North Carolina, United States
- Atsena Therapeutics, Inc.Durham, North Carolina, United States
- Scion Neurostim, Inc.Durham, North Carolina, United States
- Sapere Bio, Inc.Durham, North Carolina, United States
- BioAesthetics CorpDurham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.